Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAstraZeneca announces FDA acceptance of New Drug Application for VIMOVO
AstraZeneca, 09/04/09
AstraZeneca announced that the US Food and Drug Administration has accepted the New Drug Application submitted on June 2009 by its development partner, POZEN, Inc., for VIMOVO tablets. VIMOVO is a fixed–dose combination of enteric–coated naproxen, a pain–relieving non–steroidal anti–inflammatory drug and immediate release esomeprazole, a proton pump inhibitor, under investigation for the treatment of the signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients who are at risk of developing NSAID–associated gastric ulcers.
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/22/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
Sponsor
Article Search
Sponsor